Drugs Made In America Acquisition Corp.
A SPAC seeking to acquire a U.S.-based pharmaceutical manufacturing company.
DMAA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 2 PELICAN DR., 33301 FORT LAUDERDALE
- Website:
- https://dmaacorp.com/
- Sector:
- Mining and quarrying
- Industry:
- Extraction of natural gas
Description
Drugs Made In America Acquisition Corp. is a special purpose acquisition company (SPAC), also known as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, or other similar business combination. While not limited to a specific industry, the company intends to focus its search for a target business within the pharmaceutical sector, particularly U.S.-based companies involved in domestic manufacturing. In January 2025, the company announced the closing of its $200 million initial public offering to fund a future acquisition.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Drugs Made In America Acquisition Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Drugs Made In America Acquisition Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Drugs Made In America Acquisition Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
